Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ultra-low Dose, DaT-SPECT-guided Radiation Therapy for the Treatment of Parkinson's Disease

NCT07218952 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07218952
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07218952 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ultra-low Dose, DaT-SPECT-guided Radiation Therapy for the Treatment of Parkinson's Disease
Lead sponsor
Mayo Clinic
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
January 20, 2026
Completion date
October 31, 2027
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease